Compounds > dactinomycin

dactinomycin and Pulmonary Disease, Chronic Obstructive

dactinomycin has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertolini, S; Facchinetti, F; Iadicicco, C; Kaur, M; Marchini, G; Moretto, N; Patacchini, R; Singh, D; Volpi, G1

Trials

1 trial(s) available for dactinomycin and Pulmonary Disease, Chronic Obstructive

ArticleYear
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells.
    American journal of physiology. Lung cellular and molecular physiology, 2012, Nov-15, Volume: 303, Issue:10

    Topics: Acrolein; Bronchi; Cells, Cultured; Chemotaxis; Dactinomycin; Epithelial Cells; Female; Humans; Interleukin-8; Intracellular Signaling Peptides and Proteins; Male; MAP Kinase Signaling System; Middle Aged; Myocytes, Smooth Muscle; Neutrophil Activation; Neutrophils; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Pneumonia; Protein Serine-Threonine Kinases; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; RNA Stability; RNA, Messenger; Tobacco Smoke Pollution

2012